Neuro-Oncology

Protocols

Glioma (Adjuvant)
Glioma (Advanced)
Primary Neuroectodermal Tumours (PNET)
Pituitary
Others

Glioma (Adjuvant)

CNAJ12TZRT

Concomitant (Dual Modality) and 12 Cycles of Adjuvant Temozolomide for Newly Diagnosed Malignant Gliomas with Radiation

CNAJTZRT

Concomitant (Dual Modality) and Adjuvant Temozolomide for Newly Diagnosed Malignant Gliomas with Radiation

CNELTZRT

Treatment of Elderly Newly Diagnosed Glioma Patient with Concurrent and Adjuvant Temozolomide and Radiation Therapy

Top

Glioma (Advanced)

CNBEV

Palliative Therapy for Recurrent Malignant Gliomas Using Bevacizumab With or Without Concurrent Etoposide or Lomustine

CNCARV

CARBOplatin and Etoposide in the Treatment of Recurrent Ependymoma

CNCCNU

Lomustine (CCNU) for Treatment of Recurrent Malignant Brain Tumours

CNETO

Palliative Treatment of Patients with Recurrent Malignant Gliomas and Ependymoma Using Low Dose Etoposide

CNMODPCV

Modified PCV Chemotherapy of Brain Tumours Using Procarbazine, Lomustine (CCNU) and vinCRIstine

CNPROC

Standard Procarbazine for Second Line Treatment of Recurrent Brain Tumour

CNTEM60

Therapy for Newly Diagnosed Malignant Brain Tumours with MGMT Methylation in Elderly Patients using Temozolomide

CNTEMOZ

Therapy for Malignant Brain Tumours Using Temozolomide

CNTEMOZMD

Therapy for Malignant Brain Tumours using Metronomic Dosing of Temozolomide

CNTMZETO

Therapy for Recurrent Malignant Brain Tumours using Temozolomide and Etoposide

Top

Primary Neuroectodermal Tumours (PNET)

CNCCV

Adjuvant lomustine, CISplatin and vinCRIstine in Adult High-Risk Medulloblastoma or Other Primitive Neuroectodermal Tumour

CNCCV Protocol
See Regional Preprinted Orders for Inpatient

CNMODPCV

Modified PCV Chemotherapy of Brain Tumours Using Procarbazine, Lomustine (CCNU) and vinCRIstine

See Glioma, Advanced

Top

Pituitary

CNB

Therapy for Pituitary Adenomas Using Bromocriptine

CNCAB

Therapy for Pituitary Adenomas Using Cabergoline

CNLAN

Treatment of Growth Hormone Secreting Pituitary Adenoma Using Lanreotide (SOMATULINE AUTOGEL®)

CNOCTLAR

Treatment of Growth Hormone Secreting Pituitary Adenoma Using Octreotide

CNQUIN (deleted 01 Feb 2022)

Therapy for Pituitary Adenomas Using Quinagolide

Top

Others

USATEMBEV (See Sarcoma page)

Therapy for Advanced Solitary Fibrous Tumours and Hemangiopericytoma Using Temozolomide and Bevacizumab

Funding Algorithm

The funding algorithm provides information on what anti-cancer systemic therapy treatments are covered on the BC Cancer Benefit Drug List (formulary). It may not be a complete list of all treatment options that may be available and recommended by the treating physician.

The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer's Terms of Use.

Tab Heading